New research shows exciting advancements in the treatment of metastatic breast cancer.
KSHB's Cynthia Newsome, who announced her own battle with metastatic breast cancer earlier this year, interviewed Dr. Timothy Pluard, medical director and oncologist with Saint Luke's Hospital Koontz Center for Advanced Breast Cancer, about the latest developments for Breast Cancer Awareness Month.
One of which was a recent clinical trial for a new HER2+ metastatic breast cancer drug. The new drug, called Tucatinib, showed improvements in overall survival and worked in patients with brain metastases. Saint Luke's was one of the sites participating in the trial.
"It emphasizes the importance of clinical trials because all of these advances come through clinical trials, which is something we've very focused on at the Koontz Center," Dr. Pluard said.
Watch the full interview below.